Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage (MODISH)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The goal in this research is to develop better ways to detect and treat the damage caused by bleeding in the brain.
Condition or disease
Patients who suffer from a bleeding in the brain (stroke or hemorrhage) often experience secondary complications that can occur up to 2 weeks after the initial bleeding. Complications can include decrease of consciousness, weakness or paralysis, difficulty with speech and language, and worsening of brain damage. These decrease a patient's chances for a good recovery. A brain scan will be used to determine the damage caused by the bleeding, and the brain's electrical activity will be monitored to detect abnormal activity. These measures will be analyzed together with routine medical information to better understand and diagnose complications.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with subarachnoid hemmorhage clinical symptoms
Age 18 to 70 years
World Federation of Neurosurgery (WFNS) grade III-IV, and grade V patients who improve within 24h after ventriculostomy
Diffuse thick or localized thick subarachnoid clot >1 mm on baseline CT (Fisher grade 3-4)
Ruptured saccular aneurysm demonstrated by CT-angiography or DSA
Onset of aSAH clinical symptoms within the preceding 72h
Treatment of aneurysm within 24 h after admission
Treatment of aneurysm by clip ligation
SAH due to other causes (e.g. trauma, fusiform or mycotic aneurysm)
Only a thin diffuse layer or no visible subarachnoid blood in the initial CT
Admission in a clinical state with unfavourable prognosis (e.g., bilateral dilated, non-reactive pupils for more than 1h)
Coagulopathy (thrombocytes <60,000/ml or INR>1.5)
Presence of incompatibilities for MRI, such as non-removable metals, artificial joints, electronic devices (pace maker, pumps), etc.